Drawing for DERMAZENE

USPTO serial 77957367

DERMAZENE

Reviewed by CopyMark Law Group

Reg. 3863857Status 710
Filing date
Status date
Registration date
Oct 19, 2010
Examiner
GUSTASON, ANNE C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DERMAZENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-itch cream; Antibiotic creams; Antifungal creams for medical use; Antimicrobials for dermatologic use; Dermatological pharmaceutical products; Dermatologicals; Gels, creams and solutions for dermatological use; Hydrocortisone cream; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for use in dermatologySECTION 8 - CANCELLEDMay 1, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 26, 2017C8..CANCELLED SEC. 8 (6-YR)—
Oct 19, 2015REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 19, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 3, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 29, 2010ALIEASSIGNED TO LIE—
Jun 16, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2010DOCKASSIGNED TO EXAMINER—
Mar 17, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance